Cargando…
Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
This mini-review provides a perspective of traditional, emerging and future applications of lactic acid bacteria (LAB) and how genome editing tools can be used to overcome current challenges in all these applications. It also describes available tools and how these can be further developed, and take...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322438/ https://www.ncbi.nlm.nih.gov/pubmed/30561594 http://dx.doi.org/10.1093/femsle/fny291 |
_version_ | 1783385611306008576 |
---|---|
author | Börner, Rosa A Kandasamy, Vijayalakshmi Axelsen, Amalie M Nielsen, Alex T Bosma, Elleke F |
author_facet | Börner, Rosa A Kandasamy, Vijayalakshmi Axelsen, Amalie M Nielsen, Alex T Bosma, Elleke F |
author_sort | Börner, Rosa A |
collection | PubMed |
description | This mini-review provides a perspective of traditional, emerging and future applications of lactic acid bacteria (LAB) and how genome editing tools can be used to overcome current challenges in all these applications. It also describes available tools and how these can be further developed, and takes current legislation into account. Genome editing tools are necessary for the construction of strains for new applications and products, but can also play a crucial role in traditional ones, such as food and probiotics, as a research tool for gaining mechanistic insights and discovering new properties. Traditionally, recombinant DNA techniques for LAB have strongly focused on being food-grade, but they lack speed and the number of genetically tractable strains is still rather limited. Further tool development will enable rapid construction of multiple mutants or mutant libraries on a genomic level in a wide variety of LAB strains. We also propose an iterative Design–Build–Test–Learn workflow cycle for LAB cell factory development based on systems biology, with ‘cell factory’ expanding beyond its traditional meaning of production strains and making use of genome editing tools to advance LAB understanding, applications and strain development. |
format | Online Article Text |
id | pubmed-6322438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-63224382019-01-10 Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech Börner, Rosa A Kandasamy, Vijayalakshmi Axelsen, Amalie M Nielsen, Alex T Bosma, Elleke F FEMS Microbiol Lett Minireview This mini-review provides a perspective of traditional, emerging and future applications of lactic acid bacteria (LAB) and how genome editing tools can be used to overcome current challenges in all these applications. It also describes available tools and how these can be further developed, and takes current legislation into account. Genome editing tools are necessary for the construction of strains for new applications and products, but can also play a crucial role in traditional ones, such as food and probiotics, as a research tool for gaining mechanistic insights and discovering new properties. Traditionally, recombinant DNA techniques for LAB have strongly focused on being food-grade, but they lack speed and the number of genetically tractable strains is still rather limited. Further tool development will enable rapid construction of multiple mutants or mutant libraries on a genomic level in a wide variety of LAB strains. We also propose an iterative Design–Build–Test–Learn workflow cycle for LAB cell factory development based on systems biology, with ‘cell factory’ expanding beyond its traditional meaning of production strains and making use of genome editing tools to advance LAB understanding, applications and strain development. Oxford University Press 2018-12-18 /pmc/articles/PMC6322438/ /pubmed/30561594 http://dx.doi.org/10.1093/femsle/fny291 Text en © FEMS 2018. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Minireview Börner, Rosa A Kandasamy, Vijayalakshmi Axelsen, Amalie M Nielsen, Alex T Bosma, Elleke F Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech |
title | Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech |
title_full | Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech |
title_fullStr | Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech |
title_full_unstemmed | Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech |
title_short | Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech |
title_sort | genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech |
topic | Minireview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322438/ https://www.ncbi.nlm.nih.gov/pubmed/30561594 http://dx.doi.org/10.1093/femsle/fny291 |
work_keys_str_mv | AT bornerrosaa genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech AT kandasamyvijayalakshmi genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech AT axelsenamaliem genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech AT nielsenalext genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech AT bosmaellekef genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech |